Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease Therapy
| Image |  |
|---|---|
| Description | scientific article published on 18 March 2020 |
| Author/s |
author: Gary R Lichtenstein |
| Publication date | March 18, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |